Telix Pharmaceuticals Limited American Depositary Shares Earnings Dividend

Telix Pharmaceuticals Limited American Depositary Shares’s revenue jumped 755.13% since last year same period to $1.67Mn in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Limited American Depositary Shares has generated -74.78% fall in its revenue since last 3-months.

Telix Pharmaceuticals Limited American Depositary Shares’s net profit fell -102.52% since last year same period to $-17.5Mn in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Limited American Depositary Shares has generated -14530.68% fall in its net profits since last 3-months.

Telix Pharmaceuticals Limited American Depositary Shares’s net profit margin jumped 76.32% since last year same period to -1049.33% in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Limited American Depositary Shares has generated -57326.66% fall in its net profit margins since last 3-months.

Telix Pharmaceuticals Limited American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at 0.08 - a 155.4% jump from last quarter’s estimates.

Telix Pharmaceuticals Limited American Depositary Shares’s earning per share (EPS) estimates for the current year stand at 0.08.

Telix Pharmaceuticals Limited American Depositary Shares’s earning per share (EPS) fell -33.33% since last year same period to 0.04 in the Q4 2025. This indicates that the Telix Pharmaceuticals Limited American Depositary Shares has generated -33.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.